AIHP Announces 2026 Slate of Board Nominees

AIHP’s Nominations Committee has announced the nominees for positions on the Institute’s Board of Directors for 2026.

This year, three candidates are running for three open positions, each a three-year term. The Committee has nominated Dr. Nancy Alvarez, PharmD, BCPS, FAPhA, CPCC to stand for election as Vice President (a position currently she currently holds and filled in 2025 when it became vacant as then Vice President Boyle became President), Patricia Kienle, MPA, BCSCP, FASHP, to stand for election as Secretary (a position she currenlty holds and filled in 2025 when it became vacant as then Secretary Alvarez became Vice President), and Dr. Jeff Sturchio, PhD, to stand for an open director position (a position he currently holds; this would be his second and final consecutive term if elected).

Nancy Alvarez, PharmD, BCPS, FAPhA, CPCC, is the Associate Dean for Academic and Professional Affairs at the R. Ken Coit College of Pharmacy at The University of Arizona, where she oversees all aspects of the Phoenix branch location. She is also a Professor of Practice for the Department of Pharmacy Practice and Science. She received a Doctor of Pharmacy degree from the University of Arizona in 1992 and is a board‐certified pharmacotherapy specialist.

Dr. Alvarez served as the President of the American Pharmacists Association from 2017-2018 and served three terms on the organization’s Board of Trustees. She has served as President of the Phi Lambda Sigma Leadership Society and vice president for collegiate affairs for the Phi Delta Chi Professional Fraternity. She participates in leader development for the Pharmacy Leadership and Education Institute as a facilitator, content developer, and program director. She is the co-author of Lead Grow Shape: A Prescription for Life-Long Leader Development Workbook (2018) and co-author and editor of Bypass Pharmacy Burnout: Changing Your Trajectory to Enhance Your Experience (2021).

Dr. Alvarez received the 2021 Linwood F. Tice Friend of APhA-ASP Award from the American Pharmacists Association Academy of Student Pharmacists (APhA–ASP). In 2020, she received APhA’s Gloria Niemeyer Francke Leadership Mentor Award.

Dr. Alvarez’s practice experiences include community-based pharmacy practice, end-of-life care, and medical communications in the pharmaceutical industry. She has been an AIHP member since 2019.

Patricia C. Kienle, MPA, BCSCP, FASHP, is the Director of Accreditation and Medication Safety for Cardinal Health Innovative Delivery Solutions, where she leads efforts to ensure that Cardinal Health’s client hospitals establish and maintain comprehensive, safe, and effective medication use systems. A nationally recognized expert in medication safety, quality assurance in sterile product and hazardous drug preparation, and accreditation and regulatory compliance, Ms. Kienle has worked as a practitioner and pharmacy director and medication safety leader in hospitals and health systems.

Ms. Kienle is a graduate of the University of the Sciences in Philadelphia and Marywood University in Scranton, PA. She is an adjunct clinical faculty member at Wilkes University in Wilkes-Barre, PA. She completed an Executive Fellowship in Patient Safety from Virginia Commonwealth University.

She served on ASHP’s Board of Directors and was president of the Pennsylvania Society of Health-System Pharmacists (PSHP). She is a member of the United States Pharmacopeia Compounding Expert Committee and was chair of its subcommittee and expert panel on hazardous drugs. She also has served on the Board of Pharmacy Specialties Pharmacotherapy Specialty Council and the Board of Governors of the National Patient Safety Foundation.

Ms. Kienle’s awards and honors include the 2022 Harvey A.K. Whitney Lecture Award, health-system pharmacy’s highest honor; the 2014 ASHP Award for Distinguished Pharmacy Leadership; the ASHP John W. Webb Lecture Award; and the PSHP Sister Gonzales Duffy Lecture Award and Pharmacist of the Year.

Ms. Kienle has been an AIHP member since 1983 and is a member of the Institute’s Awards Committee.

Jeffrey L. Sturchio, PhD, is an accomplished historian of the history of medicine and science and an experienced executive in the healthcare, pharmaceutical, and nonprofit sectors. He has been a member of AIHP since 1989.

Dr. Sturchio is a graduate of Princeton University and the University of Pennsylvania, where he received a PhD in the history and sociology of science. He is the former CEO of Rabin Martin, a global health strategy consulting firm, and former president and CEO of the Global Health Council. Earlier, he was vice president of corporate responsibility at Merck & Co. Inc. and president of the Merck Company Foundation.

Dr. Sturchio is currently a visiting scholar at the Institute for Applied Economics, Global Health, and the Study of Business Enterprise at Johns Hopkins University and a Senior Associate at the Global Health Policy Center of the Center for Strategic and International Studies. He also serves as chairman of Friends of the Global Fight Against AIDS, TB, and Malaria and as chairman of the International Society for Urban Health. Dr. Sturchio is also a fellow of the American Association for the Advancement of Science and a member of both the Council on Foreign Relations and the Arthur W. Page Society.

His publications include Road to Universal Health Coverage: Innovation, Equity and the New Health Economy (edited with I. Kickbusch and L. Galambos, Johns Hopkins University Press, 2019); Noncommunicable Diseases in the Developing World: Addressing Gaps in Global Policy and Research (edited with L. Galambos, Johns Hopkins University Press, 2013); and Values & Visions: A Merck Century (Rahway, New Jersey: Merck & Co., Inc., 1991).

As required by AIHP’s bylaws, the Nominations Committee will present these nominees at the Institute’s Annual Business Meeting, which will be held Thursday, November 6, starting at 3:00 pm Central.

Under AIHP bylaws, any member in attendance at the Annual Business Meeting can nominate additional candidates if seconded by two other members. The Nominations Committee’s slate, plus any additional members nominated at the meeting, will appear on a digital ballot circulated to members later in November. The elected directors will take office in January 2026.

Posted October 6, 2025